TNGX - Tango Therapeutics GAAP EPS of -$0.23 beats by $0.08 revenue of $14.6M beats by $7.65M
2023-08-07 07:19:02 ET
- Tango Therapeutics press release ( NASDAQ: TNGX ): Q2 GAAP EPS of -$0.23 beats by $0.08 .
- Revenue of $14.6M (+152.6% Y/Y) beats by $7.65M .
For further details see:
Tango Therapeutics GAAP EPS of -$0.23 beats by $0.08, revenue of $14.6M beats by $7.65M